logo

Can Redhill Biopharma Ltd. ADR Bounce Back? 52-Week Performance and Analyst Predictions

Redhill Biopharma Ltd. ADR saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $82.00 on 11/29/23, while the lowest price for the same duration was marked at $6.43 on 10/13/23.

52-week price history of RDHL Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Redhill Biopharma Ltd. ADR’s current trading price is -89.72% away from its 52-week high, while its distance from the 52-week low is 31.21%. The stock’s price range during this period has spanned from $6.43 to $82.00. In the Healthcare sector, the Redhill Biopharma Ltd. ADR’s shares surpassed a trading volume of approximately 0.66 million for the day, which was noticeably higher compared to the average daily volume of 9.0.3 million over the past three months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Market Capitalization and Financial Performance: An In-Depth Look

Redhill Biopharma Ltd. ADR (RDHL) has experienced a quarterly decline of -27.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 10.71M and boasts a workforce of 53 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 10.59, with a change in price of -4.82. Similarly, Redhill Biopharma Ltd. ADR recorded 202,103 in trading volume during the last 100 days, posting a change of -36.38%.

Examining RDHL’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for RDHL stands at 0.66. Similarly, the long-term debt-to-equity ratio is also 0.29.

RDHL Stock Stochastic Average

Today, Redhill Biopharma Ltd. ADR’s raw stochastic average for the past 50 days stands at 12.10%, indicating a rise from the raw stochastic average of the last 20 days, which was 12.10%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 16.28% and 20.17% respectively.

RDHL Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance recorded a decrease of -76.90%. However, over the last six months, the performance has been stronger by -36.21%. The price of RDHL decreased -15.02% over the last 30 days. And in the last five days, it has surged by 5.01%.

Most Popular